norepinephrine reuptake inhibitors/5-HT2A receptor antagonists (Wyeth)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namenorepinephrine reuptake inhibitors/5-HT2A receptor antagonists (Wyeth)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNorepinephrine reuptake inhibitorsSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorNorepinephrine transporter
Therapy Area/IndicationsMood Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Llc
Active IndicationsN/A
Inactive IndicationsMood Disorders

Other Information

ATC CodeN/A
Related LinksN/A